Cardiac tumors-sex-related characteristics and outcomes after surgical resection.
cardiac masses
cardiac surgery
cardiac tumors
fibroelastoma
gender study
metastases
myxoma
Journal
Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
revised:
18
05
2022
received:
25
03
2022
accepted:
22
05
2022
pubmed:
7
6
2022
medline:
13
8
2022
entrez:
6
6
2022
Statut:
ppublish
Résumé
Cardiac tumors represent a rare and heterogeneous pathological entity, with a cumulative incidence of up to 0.02%. Gender was previously reported to influence outcomes after tumor surgery. This study aimed to investigate for gender-related differences in outcomes after cardiac surgery. Between 2009 and 2021, 95 male and 88 female patients underwent surgery for tumor extirpation in our center. Preoperative baseline characteristics, intraoperative data, and long-term survival were analyzed. The diagnosis was confirmed postoperatively by (immune-)histopathological analysis. There were no significant differences in baseline characteristics and survival. Myxoma was the most common tumor type overall and was more diagnosed in women (n = 36 vs. n = 62, p ≤ 0.001). Sarcoma was the most common malignant tumor type (n = 5). Tumor location at the atrial septum was more likely in women (n = 26 vs. n = 16, p = 0.041), whereas ventricular localization was more common in male patients (n = 20 vs. n = 7, p = 0.001). Minimally invasive tumor extirpation was significantly more often performed in women, and in-hospital stay was shorter in female patients. The localization and dignity of cardiac tumors differ between genders, not affecting survival. Surgical tumor extirpation remains the gold standard of treatment for cardiac tumors in both genders as it is highly effective and associated with good long-term survivorship.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
823-829Informations de copyright
© 2022 The Authors. Journal of Surgical Oncology published by Wiley Periodicals LLC.
Références
Molina JE, Edwards JE, Ward HB. Primary cardiac tumors: experience at the University of Minnesota. Thorac Cardiovasc Surg. 1990;38(Suppl 2):183-191.
Cresti A, Chiavarelli M, Glauber M, et al. Incidence rate of primary cardiac tumors: a 14-year population study. J Cardiovasc Med. 2016;17(1):37-43.
Oliveira GH, Al-Kindi SG, Hoimes C, Park SJ. Characteristics and survival of malignant cardiac tumors: a 40-year analysis of >500 patients. Circulation. 2015;132(25):2395-2402.
Tyebally S, Chen D, Bhattacharyya S, et al. Cardiac tumors: JACC CardioOncology state-of-the-art review. JACC CardioOncol. 2020;2(2):293-311.
Zaragoza-Macias E, Chen MA, Gill EA. Real time three-dimensional echocardiography evaluation of intracardiac masses. Echocardiography. 2012;29(2):207-219.
Beroukhim RS, Prakash A, Valsangiacomo Buechel ER, et al. Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience. J Am Coll Cardiol. 2011;58(10):1044-1054.
Kassop D, Donovan MS, Cheezum MK, et al. Cardiac masses on cardiac CT: a review. Curr Cardiovasc Imaging Rep. 2014;7(8):9281.
Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Sex differences in mortality after coronary artery bypass graft surgery mortality after coronary artery bypass graft surgery. JAMA. 2004;292(1):40-41.
Gaisendrees C, Djordjevic I, Sabashnikov A, et al. Gender-related differences in treatment and outcome of eCPR-patients. Artif Organs. 2020
Antwi-Amoabeng D, Meghji Z, Thakkar S, et al. Survival differences in men and women with primary malignant cardiac tumor: an analysis using the surveillance, epidemiology and end results (SEER) database from 1973 to 2015. J Am Heart Assoc. 2020;9(10):e014846.
Rahouma M, Baudo M, Shmushkevich S, et al. Sex differences in primary malignant cardiac tumors: a multi-institutional cohort study from National Cancer Database. J Card Surg. 2022;37(5):1275-1286.
Öztuna D, Elhan AH, Tüccar E. Investigation of four different normality tests in terms of type 1 error rate and power under different distributions. Turk J Med Sci. 2006;36(3):171-176.
Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Cardiac tumors-diagnosis and surgical treatment. Dtsch Arztebl Int. 2014;111(12):205-211.
Keeling I. Cardiac myxomas: 24 years of experience in 49 patients. European J Cardio-Thoracic Surg. 2002;22(6):971-977.
Mkalaluh S, Szczechowicz M, Torabi S, et al. Surgical treatment of cardiac tumors: insights from an 18-Year Single-Center analysis. Med Sci Monit. 2017;23:6201-6209.
Moeri-Schimmel R, Pras E, Desar I, Krol S, Braam P. Primary sarcoma of the heart: case report and literature review. J Cardiothorac Surg. 2020;15(1):104.
Burke AP, Cowan D, Virmani R. Primary sarcomas of the heart. Cancer. 1992;69(2):387-395.
Hudzik B, Miszalski-Jamka K, Glowacki J, et al. Malignant tumors of the heart. Cancer epidemiology. 2015;39(5):665-672.
Ramlawi B, Leja MJ, Abu Saleh WK, et al. Surgical treatment of primary cardiac sarcomas: review of a single-institution experience. Ann Thorac Surg. 2016;101(2):698-702.
Devbhandari MP, Meraj S, Jones MT, Kadir I, Bridgewater B. Primary cardiac sarcoma: reports of two cases and a review of current literature. J Cardiothorac Surg. 2007;2:34.
Gaisendrees C, Mader N, Sabashnikov A, Schlachtenberger G, Suhr L, Wahlers T. Minimally invasive resection of a giant left atrial myxoma: a case report. Perfusion. 2020;35(3):263-266.
Ellouze M, Pellerin M, Jeanmart H, Lebon JS, Bouchard D. Mini right anterior thoracotomy approach versus sternotomy for resection of intracardiac myxoma. Innovations. 2018;13(4):292-295.
Centofanti P, Di Rosa E, Deorsola L, et al. Primary cardiac tumors: early and late results of surgical treatment in 91 patients. Ann Thorac Surg. 1999;68(4):1236-1241.
Spetz J, Moslehi J, Sarosiek K. Radiation-Induced cardiovascular toxicity: mechanisms, prevention, and treatment. Curr Treat Options Cardiovasc Med. 2018;20(4):31.
Llombart-Cussac A, Pivot X, Contesso G, et al. Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experience. Br J Cancer. 1998;78(12):1624-1628.
Endo A, Ohtahara A, Kinugawa T, et al. Characteristics of 161 patients with cardiac tumors diagnosed during 1993 and 1994 in Japan. Am J Cardiol. 1997;79(12):1708-1711.
Putnam JB, Jr., Sweeney MS, Colon R, Lanza LA, Frazier OH, Cooley DA. Primary cardiac sarcomas. Ann Thorac Surg. 1991;51(6):906-910.
Taguchi S. Comprehensive review of the epidemiology and treatments for malignant adult cardiac tumors. Gen Thorac Cardiovasc Surg. 2018;66(5):257-262.